| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.9M | — | -36.5% |
| Cost of Revenue | $8.9M | — | -29.6% |
| Gross Profit | $12.0M | — | -40.9% |
| R&D Expense | $435K | — | -1.8% |
| SG&A Expense | $6.3M | — | -16.7% |
| Operating Income | -$2.9M | — | -375.0% |
| Interest Expense | $599K | — | -42.7% |
| Pre-tax Income | -$3.1M | — | -9378.8% |
| Income Tax | $27K | — | +208.0% |
| Net Income | -$3.1M | — | -5425.9% |
| EPS (Basic) | -$0.02 | — | — |
| EPS (Diluted) | -$0.02 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.1M | -28.8% | +141.2% |
| Accounts Receivable | $17.2M | -3.5% | -26.8% |
| Inventory | $31.9M | +5.3% | -17.9% |
| Current Assets | $62.6M | -20.0% | -9.4% |
| Total Assets | $78.0M | -17.1% | -18.6% |
| Current Liabilities | $18.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.1M | — | -265.4% |
| Capital Expenditures | $194K | — | -83.7% |
| Investing Cash Flow | $10.2M | — | +994.1% |
| Financing Cash Flow | -$13.3M | — | -1344.5% |
| Free Cash Flow | -$2.3M | — | -2752.9% |
| -36.5% |
| Long-term Debt | $8.1M | -26.6% | -63.5% |
| Total Liabilities | $29.4M | -31.9% | -43.4% |
| Stockholders' Equity | $48.6M | -4.6% | +10.8% |